Cspc Innovation Pharmaceutical Co.,Ltd.(300765),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

300765 Cspc Innovation Pharmaceutical Co.,Ltd.

Closed 01-10 15:00:00

25.54

+2.54

+11.04%

High26.13	Low22.80	Vol20.54M
Open23.12	D1 Closing23.00	Amplitude14.48%
Mkt Cap35.88B	Tradable Cap31.85B	Total Shares1.41B
T/O512.00M	T/O Rate1.65%	Tradable Shares1.25B
P/B8.47	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"300765","market":"SZ","secType":"STK","nameCN":"Cspc Innovation Pharmaceutical Co.,Ltd.","latestPrice":25.54,"timestamp":1736492604000,"preClose":23,"halted":0,"volume":20543706,"delay":0,"changeRate":0.1104,"floatShares":1247000000,"shares":1405000000,"eps":0.2218,"marketStatus":"Closed","change":2.54,"latestTime":"01-10 15:00:00","open":23.12,"high":26.13,"low":22.8,"amount":512000000,"amplitude":0.1448,"askPrice":25.54,"askSize":3,"bidPrice":25.53,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.2218,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1736731800000},"marketStatusCode":5,"adr":0,"adjPreClose":23,"symbolType":"stock","openAndCloseTimeList":[[1736472600000,1736479800000],[1736485200000,1736492400000]],"highLimit":25.3,"lowLimit":20.7,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1404592944,"isCdr":false,"pbRate":8.47,"roa":"--","peRate":115.148783,"roe":"2.82%","epsLYR":0.6533,"committee":0.725451,"marketValue":35873000000,"turnoverRate":0.0165,"status":0,"floatMarketCap":31850000000},"requestUrl":"/m/hq/s/300765/tweets","defaultTab":"tweets","newsList":[{"id":"2489411486","title":"CSPC Innovation Pharmaceutical Get US FDA Fast Track Qualification for Cervical Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2489411486","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489411486?lang=en_us&edition=fundamental","pubTime":"2024-12-05 15:49","pubTimestamp":1733384976,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical  was granted fast track qualification by the US Food and Drug Administration for the CRB-701 injection.The drug is used for the treatment of recurrent or refractory metastatic cervical cancer, according to a Wednesday filing with the Shenzhen bourse.Shares of the pharmaceutical company closed 2% higher Thursday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300765","IE00B5TLWC47.USD","IE00BFXG0V08.USD","BK0226","BK4567","FAST","BK4104","BK4588","IE00BYQQ9H92.USD","BK4585"],"gpt_icon":0},{"id":"2481716671","title":"CSPC Innovation Pharmaceutical  Says Key Shareholder Plans to Raise Stake in Company for 100-120 Mln Yuan Within Six Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2481716671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481716671?lang=en_us&edition=fundamental","pubTime":"2024-11-08 08:58","pubTimestamp":1731027496,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4N3MF02K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2481166057","title":"BRIEF-CSPC Innovation Says Key Shareholder Plans To Raise Co Stake For Up To 120 Mln Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=2481166057","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481166057?lang=en_us&edition=fundamental","pubTime":"2024-11-08 08:58","pubTimestamp":1731027496,"startTime":"0","endTime":"0","summary":"BRIEF-CSPC Innovation Says Key Shareholder Plans To Raise Co Stake For Up To 120 Mln Yuan Nov 8  - CSPC Innovation Pharmaceutical Co Ltd 300765.SZ:SAYS KEY SHAREHOLDER PLANS TO RAISE STAKE IN COMPANY FOR 100-120 MILLION YUAN  WITHIN SIX MONTHSSource textFurther company coverage: 300765.SZ  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL4N3MF02K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["300765","BK0226"],"gpt_icon":0},{"id":"2477581153","title":"CSPC Innovation Pharmaceutical's Q3 Profit Plunges 98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477581153","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477581153?lang=en_us&edition=fundamental","pubTime":"2024-10-23 20:24","pubTimestamp":1729686293,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical (SHE:300765) recorded a 98% decline in attributable profit in the third quarter to 2.3 million yuan from 116.9 million yuan a year prior, a Wednesday bourse filing by pa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0880133367.SGD","BK1515","LU1152091754.HKD","BK0226","IE00BZ08YT58.USD","HKD","01093","LU1807302812.USD","BK1521","BK1191","IE00BZ08YS42.EUR","IE00B031HY20.USD","BK4585","BK4023","LU1226288253.USD","LU1152091168.USD","IE00BZ08YR35.GBP","LU0140636845.USD","IE00B543WZ88.USD","SG9999004220.SGD","IE0008369823.USD","LU1226287529.USD","LU1226287792.SGD","LU1960683339.HKD","LU0072913022.USD","LU1951186391.HKD","300765","LU1008478684.HKD","LU1226287875.USD","IE00B5MMRT66.SGD","IE0008368742.USD","BK4526","LU0501845795.SGD","LU1993786604.SGD","BK4588","LU0067412154.USD","LU0326950275.SGD","LU1226288170.HKD"],"gpt_icon":0},{"id":"2460776282","title":"CSPC Innovation Pharmaceutical's H1 Profit Drops 48%, Revenue Slides 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460776282","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460776282?lang=en_us&edition=fundamental","pubTime":"2024-08-19 12:07","pubTimestamp":1724040459,"startTime":"0","endTime":"0","summary":"CSPC Innovation Pharmaceutical  recorded a net profit attributable to shareholders of 137 million yuan, dropping 48.3% from 264.9 million yuan a year earlier, according to a Saturday filing on the Shenzhen Stock Exchange.Earnings per share fell 47.4% year on year to 0.10 yuan from 0.19 yuan.The Chinese pharmaceutical company's revenue slipped 27.7% to 971.9 million yuan from 1.34 billion yuan in the preceding year, the disclosure said.Price : 23.67, Change: +0.19, Percent Change: +0.81%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["300765"],"gpt_icon":0},{"id":"2460776230","title":"CSPC Innovation Pharmaceutical's H1 Profit Drops 48%, Revenue Slides 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460776230","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2460776230?lang=en_us&edition=fundamental","pubTime":"2024-08-19 12:07","pubTimestamp":1724040459,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_live","symbols":["BK0226","SHE","300765"],"gpt_icon":0},{"id":"2459439217","title":"BRIEF-CSPC Pharmaceutical Posts HY Net Profit Attributable For CSPC Innovation Pharmaceutical Of RMB137 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2459439217","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459439217?lang=en_us&edition=fundamental","pubTime":"2024-08-16 22:03","pubTimestamp":1723817027,"startTime":"0","endTime":"0","summary":"Aug 16 (Reuters) - CSPC Pharmaceutical Group Ltd :   * HY NET PROFIT ATTRIBUTABLE FOR CSPC INNOVATION PHARMACEUTICAL RMB137 MILLION   * HY REVENUE FOR  CSPC INNOVATION PHARMACEUTICAL RMB971.9 MILLIONFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0072913022.USD","SG9999004220.SGD","01093","LU1152091168.USD","IE00B543WZ88.USD","IE0008368742.USD","BK0226","BK1521","BK1191","LU1008478684.HKD","IE0008369823.USD","LU0067412154.USD","LU0880133367.SGD","IE00B031HY20.USD","IE00B5MMRT66.SGD","LU1152091754.HKD","LU0140636845.USD","LU0326950275.SGD","LU1807302812.USD","BK1515","LU1226287529.USD","LU1993786604.SGD","LU0501845795.SGD","LU1960683339.HKD","300765"],"gpt_icon":0},{"id":"2459437291","title":"CSPC Pharmaceutical - Hy Net Profit Attributable for CSPC Innovation Pharmaceutical RMB137 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2459437291","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2459437291?lang=en_us&edition=fundamental","pubTime":"2024-08-16 18:29","pubTimestamp":1723804160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240816:nFWN3K30VJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0008369823.USD","300765","LU1960683339.HKD","LU0501845795.SGD","LU0072913022.USD","BK0226","LU1993786604.SGD","IE00B543WZ88.USD","LU1226287529.USD","BK1521","BK1191","LU1008478684.HKD","LU0880133367.SGD","IE0008368742.USD","LU0067412154.USD","SG9999004220.SGD","LU1152091754.HKD","IE00B031HY20.USD","01093","IE00B5MMRT66.SGD","LU0140636845.USD","LU0326950275.SGD","LU1152091168.USD","LU1807302812.USD","BK1515"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2019-03-22","address":"河北省石家庄市栾城区张举路62号","stockEarnings":[{"period":"1week","weight":-0.0963},{"period":"1month","weight":-0.2251},{"period":"3month","weight":-0.2626},{"period":"6month","weight":-0.0763},{"period":"1year","weight":-0.2008},{"period":"ytd","weight":-0.135}],"companyName":"石药创新制药股份有限公司","boardCode":"AI0014","perCapita":"79274股","boardName":"食品制造业","registeredCapital":"140459万元","compareEarnings":[{"period":"1week","weight":-0.0157},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.002},{"period":"6month","weight":0.0808},{"period":"1year","weight":0.116},{"period":"ytd","weight":-0.0419}],"survey":"　　石药创新制药股份有限公司的主营业务是大健康领域功能食品的研发、生产与销售。公司的主要产品为功能性原料及保健食品类产品。公司“果维康”商标为中国驰名商标，“果维康”牌维生素C含片先后获得中国公众营养和发展中心“营养健康倡导产品”、“中华预防医学会健康金桥重点工程项目”、等多项荣誉。公司二甲紫脲酸高选择性催化还原新工艺,可可碱生产新工艺经河北省科学技术厅的认定，达到国内领先水平，并获得了河北省科学技术成果奖。公司专利“一种咖啡因中间体N，N-1，3-二甲基-4，5-二氨基脲嗪的制备方法”荣获2018年河北省专利奖优秀奖。","serverTime":1736496497301,"listedPrice":24.47,"stockholders":"15731人(较上一季度减少4.59%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cspc Innovation Pharmaceutical Co.,Ltd.(300765),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Cspc Innovation Pharmaceutical Co.,Ltd.(300765) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Cspc Innovation Pharmaceutical Co.,Ltd.,300765,Cspc Innovation Pharmaceutical Co.,Ltd.股票,Cspc Innovation Pharmaceutical Co.,Ltd.股票老虎,Cspc Innovation Pharmaceutical Co.,Ltd.股票老虎国际,Cspc Innovation Pharmaceutical Co.,Ltd.行情,Cspc Innovation Pharmaceutical Co.,Ltd.股票行情,Cspc Innovation Pharmaceutical Co.,Ltd.股价,Cspc Innovation Pharmaceutical Co.,Ltd.股市,Cspc Innovation Pharmaceutical Co.,Ltd.股票价格,Cspc Innovation Pharmaceutical Co.,Ltd.股票交易,Cspc Innovation Pharmaceutical Co.,Ltd.股票购买,Cspc Innovation Pharmaceutical Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cspc Innovation Pharmaceutical Co.,Ltd.(300765),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Cspc Innovation Pharmaceutical Co.,Ltd.(300765) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction